Zolbetuximab Approved to Treat Adults with Stomach or Gastro-oesophageal Junction Cancer

Zolbetuximab (Vyloy) is a monoclonal antibody that can recognise and attach itself to certain cancer cells to destroy them.

Follow this news feed: